1. OVERDOSAGE

2. RECOGNITION.  HIGH INDEX OF SUSPICION.  CARFUL CLINICAL EVALUATION.  INFORMATION FROM FAMILY OR FRIENDS.  OBTAIN SUPPORTING MATERIALS.  SPECIFIC TOXIC SYNDROMES.  VITAL SIGNS, NEUROLOGIC STATUS,PUPILLARY REACTIONS,ABDOMINAL FINDINGS AND UNUSUAL ODORS AND EXCRETA  ABG, ELECTROLYTES AND ACID-BASE.  SCREENING,BLOOD AND URIN – XRAY-ECG.

18. SUPPORTIVE CARE.  MAINTAIN A PATENT AIRWAY.  MAINTAIN BLOOD PRESSURE.  ARRHYTHMIAS.  CNS DEPRESSION – NALOXONE-50%DEXTROSE- THAIMINE.

19. PREVENTION OF ABSORRPTION.  ACTIVATED CHARCOAL.  GASTRIC EMPTYING.

20. ACTIVATED CHARCOAL.  ADSORBS MOST DRUGS,PREVENTING FURTHER ABSORBTION FROM GI.  EXCEPTIONS INCLUDE ALKALIS,ARSENIC,CYANIDE,ETHANOL,LITHIU M, AND MINERAL ACIDS.  50-100 G INITIALY THEN 12.5 G/H UNTIL THE PATIENT CONDITION AND LABORATORY PARAMETERS IMPROVE.

21. GASTRIC EMPTYING. AIRWAY MUST BE PROTECTED. AIRWAY MUST BE PROTECTED. IPECAC. IPECAC. GASTRIC LAVAGE. GASTRIC LAVAGE. WHOLE-BOWEL IRRIGATION WHOLE-BOWEL IRRIGATION

22. REMOVAL OF ABSORBED DRUGS  FORCED ALKALINE DIURESIS ACHIEVING A URRINARY PH 7-9, PROMOTES EXCRETION OF DRUGS THAT ARE WEAK ACID  SODIUM BICARBONATE 44-100 MEQ IN 1 LITTER OF 0.45 SALINE AT 250-500/H  EXTRACORPOREAL REMOVAL OF TOXIN BY DIALYSIS OR HEMOPERFUSION.

23. SPECIFIC ANTIDOTES

29. DISPOSITION OBSERVE FOR AT LEAST 4 H. OBSERVE FOR AT LEAST 4 H. PSYCHATRIC COSULTATION. PSYCHATRIC COSULTATION.